Why the study?
Does an ultrasound-based steatosis grading system using 2D-attenuation imaging reliably assess steatosis in patients with metabolic dysfunction-associated steatotic liver disease?
Does an ultrasound-based steatosis grading system using 2D-attenuation imaging reliably assess steatosis in patients with metabolic dysfunction-associated steatotic liver disease?
An ultrasound-based steatosis grading system using 2D-attenuation imaging provides a reliable, noninvasive method for assessing steatosis in patients with metabolic dysfunction-associated steatotic liver disease.
Answers are grounded in this paper and cite their sources.
May reduce biopsy reliance for steatosis assessment in MASLD; strengthens evidence for ATI via meta-analysis.
ATI is a reliable, noninvasive marker of steatosis. This validated ATI-based steatosis grading system could be valuable in assessing patients with metabolic dysfunction-associated steatotic liver disease.
No takes yet. Share an insight, caveat, or question.
Hobeika et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: